LA21-3 Supplementary vocabulary
LA21-3 For laboratory use
LA21-3 is a supplementary CPV code meaning For laboratory use. It is added alongside a main CPV code to qualify it - a material, a purpose, a target group - and never replaces it.
This CPV code in every EU language
For laboratory use
English (EN)
За лабораторна употреба
Български (BG)
Pro laboratorní použití
Čeština (CS)
Til laboratoriebrug
Dansk (DA)
Für den Laborbedarf
Deutsch (DE)
Για εργαστηριακή χρήση
Ελληνικά (EL)
Para uso en laboratorio
Español (ES)
Laboratooriumis kasutamiseks
Eesti (ET)
Laboratoriokäyttöön
Suomi (FI)
Pour laboratoire
Français (FR)
Za laboratorijsku uporabu
Hrvatski (HR)
Laboratóriumi használatra
Magyar (HU)
Per uso in laboratorio
Italiano (IT)
Laboratorinis
Lietuvių (LT)
Izmantošanai laboratorijās
Latviešu (LV)
Għall-użu fil-laboratorju
Malti (MT)
Voor laboratoriumgebruik
Nederlands (NL)
Do użytku laboratoryjnego
Polski (PL)
Para uso laboratorial
Português (PT)
Pentru laborator
Română (RO)
Na laboratórne použitie
Slovenčina (SK)
Za laboratorijsko uporabo
Slovenščina (SL)
För laboratoriebruk
Svenska (SV)
Commission Regulation (EC) No 213/2008 - official wording for LA21-3.
Section LA (55)
| Code | Description |
|---|---|
| LA01-3 | For anaesthetics |
| LA02-6 | For artificial-kidney treatment |
| LA03-9 | For autopsy |
| LA04-2 | For bronchial endoscopy |
| LA05-5 | For burns |
| LA06-8 | For cytostatic treatment |
| LA07-1 | For diagnostic radiology |
| LA08-4 | For dietary use |
| LA09-7 | For disinfection |
| LA10-0 | For dispensary use |
| LA11-3 | For endovascular use |
| LA12-6 | For gynaecology |
| LA13-9 | For haemodialysis |
| LA14-2 | For haemodynamics |
| LA15-5 | For heart surgery |
| LA16-8 | For hospital use |
| LA17-1 | For immunology |
| LA18-4 | For infusion |
| LA19-7 | For injection |
| LA20-0 | For intensive-care use |
| LA22-6 | For medical personnel |
| LA23-9 | For medical use |
| LA24-2 | For neuro-angiographical use |
| LA25-5 | For neuro-surgical use |